Transcriptome analysis of cell line/patient-derived xenograft (PDX) samples of myeloid leukemia associated with Down syndrome (ML-DS)

ABSTRACT: Myeloid leukemia associated with Down syndrome (ML-DS) is a rare pediatric cancer in which 10-20% patients who are relapsed/refractory have very limited treatment options. Novel treatment options may be identified via transcriptome profiling.

ORGANISM(S): Homo sapiens

PROVIDER: GSE271179 | GEO | 2026/06/18

REPOSITORIES: GEO